GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
Wall Street Today: S&P 500 Hits Record To Start Short Week
Hims & Hers Downgraded at Morgan Stanley on Recent Rally
Live Stock News: Short Week with a Slow Start
Novo Nordisk Shares Are Trading Higher. The Stock May Be Moving After Sanofi Announced FDA Approval for Merilog, Its First Rapid-acting Insular Product for Diabetes, Which Is Biosimilar to Novo Nordisk's Insulin Products.
FDA Approves Sanofi's Merilog As First Rapid-Acting Insulin Biosimilar Product For Diabetes
Trump's Tax Cut Could Add $4.6 Trillion To Deficit, With $48 Billion Tax Relief For Top 100 Firms: Robert Reich
不清醒的头脑 : Can come in![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)